| Primary |
| Product Used For Unknown Indication |
26.2% |
| Hypertension |
19.9% |
| Drug Use For Unknown Indication |
13.5% |
| Atrial Fibrillation |
5.0% |
| Cardiac Disorder |
4.3% |
| Ill-defined Disorder |
3.5% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Supraventricular Tachycardia |
2.8% |
| Arrhythmia |
2.6% |
| Depression |
2.6% |
| Migraine |
2.1% |
| Suicide Attempt |
2.1% |
| Blood Pressure |
1.9% |
| Diabetes Mellitus |
1.9% |
| Intentional Overdose |
1.9% |
| Prophylaxis |
1.7% |
| Dementia Alzheimer's Type |
1.4% |
| Palpitations |
1.4% |
| Angina Pectoris |
1.2% |
| Blood Pressure Abnormal |
1.2% |
|
| Completed Suicide |
47.0% |
| Drug Ineffective |
10.8% |
| Death |
6.5% |
| Medication Error |
4.3% |
| Overdose |
3.9% |
| Respiratory Arrest |
3.4% |
| Drug Toxicity |
2.4% |
| Toxicity To Various Agents |
2.4% |
| Intentional Overdose |
2.2% |
| Intentional Drug Misuse |
1.9% |
| Bradycardia |
1.7% |
| Drug Hypersensitivity |
1.7% |
| Hypotension |
1.7% |
| Shock |
1.7% |
| Dizziness |
1.5% |
| Drug Intolerance |
1.5% |
| Suicide Attempt |
1.5% |
| Drug Interaction |
1.3% |
| Malaise |
1.3% |
| Nausea |
1.3% |
|
| Secondary |
| Hypertension |
24.0% |
| Product Used For Unknown Indication |
19.0% |
| Atrial Fibrillation |
10.4% |
| Drug Use For Unknown Indication |
5.4% |
| Maternal Exposure Timing Unspecified |
5.0% |
| Depression |
4.3% |
| Palpitations |
3.4% |
| Suicide Attempt |
3.4% |
| Migraine |
3.3% |
| Type 2 Diabetes Mellitus |
3.1% |
| Rheumatoid Arthritis |
2.6% |
| Osteoarthritis |
2.3% |
| Insomnia |
2.2% |
| Cardiac Disorder |
2.0% |
| Hypothyroidism |
1.9% |
| Blood Pressure |
1.7% |
| Arrhythmia |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Prophylaxis |
1.5% |
| Pain |
1.4% |
|
| Completed Suicide |
13.3% |
| Drug Hypersensitivity |
11.5% |
| Drug Ineffective |
11.5% |
| Bradycardia |
7.1% |
| Vomiting |
6.2% |
| Loss Of Consciousness |
5.3% |
| Restless Legs Syndrome |
4.4% |
| Shock |
4.4% |
| Foetal Exposure During Pregnancy |
3.5% |
| Hypotension |
3.5% |
| Overdose |
3.5% |
| Toxicity To Various Agents |
3.5% |
| Weight Increased |
3.5% |
| Acute Myocardial Infarction |
2.7% |
| Blood Pressure Increased |
2.7% |
| Circulatory Collapse |
2.7% |
| Death Neonatal |
2.7% |
| Dizziness |
2.7% |
| Drug Interaction |
2.7% |
| Flushing |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.1% |
| Atrial Fibrillation |
11.9% |
| Hypertension |
11.4% |
| Prophylaxis |
7.8% |
| Cardiac Failure |
4.7% |
| Castleman's Disease |
4.7% |
| Drug Use For Unknown Indication |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Arrhythmia |
3.9% |
| Insomnia |
3.3% |
| Diabetes Mellitus |
3.1% |
| Hepatitis C |
2.9% |
| Constipation |
2.8% |
| Gastritis |
2.3% |
| Tachyarrhythmia |
1.9% |
| Osteoporosis |
1.8% |
| Pain |
1.7% |
| Depression |
1.5% |
| Hyperlipidaemia |
1.5% |
| Schizophrenia |
1.5% |
|
| International Normalised Ratio Increased |
9.6% |
| Cardiac Failure |
6.8% |
| Cerebral Infarction |
6.8% |
| Pneumonia |
6.8% |
| Interstitial Lung Disease |
6.2% |
| Renal Impairment |
5.6% |
| Supraventricular Tachycardia |
5.6% |
| Death |
5.1% |
| Vascular Headache |
5.1% |
| Anaemia |
4.5% |
| Gastrointestinal Haemorrhage |
4.5% |
| Vomiting |
4.5% |
| Lactic Acidosis |
4.0% |
| Malaise |
4.0% |
| Rhabdomyolysis |
4.0% |
| Hepatic Function Abnormal |
3.4% |
| Hypoglycaemia |
3.4% |
| Iron Deficiency Anaemia |
3.4% |
| Neutropenia |
3.4% |
| Tachycardia |
3.4% |
|
| Interacting |
| Hypertension |
17.6% |
| Atrial Fibrillation |
13.5% |
| Bronchitis |
8.1% |
| Rheumatoid Arthritis |
8.1% |
| Cerebral Infarction |
5.4% |
| Chronic Myeloid Leukaemia |
5.4% |
| Gout |
5.4% |
| Osteoporosis |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Coronary Artery Disease |
2.7% |
| Headache |
2.7% |
| Hypertonic Bladder |
2.7% |
| Lung Adenocarcinoma |
2.7% |
| Pulmonary Hypertension |
2.7% |
| Supraventricular Extrasystoles |
2.7% |
| Tachycardia |
2.7% |
| Thyroid Function Test Abnormal |
2.7% |
| Arrhythmia |
1.4% |
| Arrhythmia Supraventricular |
1.4% |
| Cardiac Failure Congestive |
1.4% |
|
| Drug Interaction |
26.7% |
| Rhinorrhoea |
10.0% |
| Atrial Fibrillation |
6.7% |
| Electrocardiogram Qt Prolonged |
6.7% |
| Mitral Valve Incompetence |
6.7% |
| Nodal Rhythm |
6.7% |
| Shock |
6.7% |
| Therapeutic Agent Toxicity |
6.7% |
| Disseminated Intravascular Coagulation |
3.3% |
| Fatigue |
3.3% |
| Liver Disorder |
3.3% |
| Maternal Exposure During Pregnancy |
3.3% |
| Pulmonary Embolism |
3.3% |
| Rhabdomyolysis |
3.3% |
| Tachycardia |
3.3% |
|
